"The French health technology company announced the news Tuesday at CES 2026. Abbott partnership Withings sells smart scales, smart watches, blood pressure monitors, and other health-tracking devices, including a recently announced urine sensor. Users can begin tracking their glucose levels collected through Abbott Lingo on the Withings app, alongside the 90 other biomarkers Withings devices can collect and monitor, in early Q1 2026."
"To do so, users pair the Withings app with Apple HealthKit (for iOS) or Personal Health Connect (for Android). Also: CES 2026 news: Live updates on TVs, smart glasses, robots, and more we've seen so far Eric Careel, Withings CEO, says the integration gives Withings users a richer and more holistic view of their overall well-being. "Through this partnership, we're making it easier for individuals to take charge of their health journey -- with insight, awareness, and confidence," said Careel in a press release."
Withings is adding glucose tracking to its app through a partnership with Abbott, maker of the over-the-counter Abbott Lingo continuous glucose monitor. Users will be able to sync Abbott Lingo glucose data into the Withings app and view it alongside about 90 other biomarkers collected by Withings devices. Pairing will occur through Apple HealthKit on iOS or Personal Health Connect on Android. Glucose tracking will become available in early Q1 2026. Withings device lineup includes smart scales, smart watches, blood pressure monitors, and a recently announced urine sensor. Continuous glucose monitors have expanded from diabetic care to broader consumer metabolic tracking and prevention.
Read at ZDNET
Unable to calculate read time
Collection
[
|
...
]